Page last updated: 2024-08-23

levamisole and interleukin-8

levamisole has been researched along with interleukin-8 in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	3 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chang, YF; Chia, JS; Chiang, CP; Sun, A	1
Chia, JS; Chiang, CP; Sun, A; Wang, JT	1
Chia, JS; Chiang, CP; Liu, BY; Sun, A; Wang, YP	1

Trials

1 trial(s) available for levamisole and interleukin-8

Article	Year
Treatment with levamisole and colchicine can result in a significant reduction of IL-6, IL-8 or TNF-alpha level in patients with mucocutaneous type of Behcet's disease. Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology, 2009, Volume: 38, Issue:5 Topics: Adjuvants, Immunologic; Adolescent; Adult; Aged; Anti-Inflammatory Agents; Behcet Syndrome; Case-Control Studies; Child; Colchicine; Cytokines; Female; Humans; Interleukin-6; Interleukin-8; Levamisole; Male; Middle Aged; Reference Values; Treatment Outcome; Tumor Necrosis Factor-alpha; Young Adult	2009

Article

Year

Treatment with levamisole and colchicine can result in a significant reduction of IL-6, IL-8 or TNF-alpha level in patients with mucocutaneous type of Behcet's disease.

Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology, 2009, Volume: 38, Issue:5

Topics: Adjuvants, Immunologic; Adolescent; Adult; Aged; Anti-Inflammatory Agents; Behcet Syndrome; Case-Control Studies; Child; Colchicine; Cytokines; Female; Humans; Interleukin-6; Interleukin-8; Levamisole; Male; Middle Aged; Reference Values; Treatment Outcome; Tumor Necrosis Factor-alpha; Young Adult

2009

Other Studies

2 other study(ies) available for levamisole and interleukin-8

Article	Year
Serum interleukin-8 level is a more sensitive marker than serum interleukin-6 level in monitoring the disease activity of recurrent aphthous ulcerations. Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology, 2004, Volume: 33, Issue:3 Topics: Adolescent; Adult; Aged; Analysis of Variance; Antirheumatic Agents; Biomarkers; Case-Control Studies; Child; Female; Humans; Interleukin-6; Interleukin-8; Levamisole; Male; Middle Aged; Sensitivity and Specificity; Stomatitis, Aphthous	2004
Serum interleukin-8 level is a more sensitive marker than serum interleukin-6 level in monitoring the disease activity of oral lichen planus. The British journal of dermatology, 2005, Volume: 152, Issue:6 Topics: Acute Disease; Adult; Aged; Analysis of Variance; Biomarkers; Female; Humans; Immunologic Factors; Interleukin-6; Interleukin-8; Levamisole; Lichen Planus, Oral; Male; Middle Aged; Mouth Mucosa; Sensitivity and Specificity	2005

Article

Year

Serum interleukin-8 level is a more sensitive marker than serum interleukin-6 level in monitoring the disease activity of recurrent aphthous ulcerations.

Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology, 2004, Volume: 33, Issue:3

Topics: Adolescent; Adult; Aged; Analysis of Variance; Antirheumatic Agents; Biomarkers; Case-Control Studies; Child; Female; Humans; Interleukin-6; Interleukin-8; Levamisole; Male; Middle Aged; Sensitivity and Specificity; Stomatitis, Aphthous

2004

Serum interleukin-8 level is a more sensitive marker than serum interleukin-6 level in monitoring the disease activity of oral lichen planus.

The British journal of dermatology, 2005, Volume: 152, Issue:6

Topics: Acute Disease; Adult; Aged; Analysis of Variance; Biomarkers; Female; Humans; Immunologic Factors; Interleukin-6; Interleukin-8; Levamisole; Lichen Planus, Oral; Male; Middle Aged; Mouth Mucosa; Sensitivity and Specificity

2005